We are live on
!
Find out more
Parallel Advisors Portfolio holdings
AUM
$6.56B
Turnover
11.49%
1-Year Est. Return
32.24%
This Fund
S&P 500
This Quarter
Est. Return
+15.2%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.41%
10 Year Est. Return
–
AUM
$1.84B
AUM Growth
+$226M
(+14%)
Cap. Flow
+$18.1M
Cap. Flow
% of AUM
0.98%
Top 10 Holdings %
Top 10 Hldgs %
36.21%
Holding
2,856
New
200
Increased
717
Reduced
1,072
Closed
193
Avg Time Held Equity + Options
2.5
years
Top 10 Avg Time Held Equity + Options
1.7
years
Top 20 Avg Time Held Equity + Options
1.8
years
Avg Time Held Equity only
2.5
years
Top 10 Avg Time Held Equity only
1.7
years
Top 20 Avg Time Held Equity only
1.8
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares US Treasury Bond ETF
GOVT
|
+$14.5M |
| 2 |
CVB Financial
CVBF
|
+$10.4M |
| 3 |
Uber
UBER
|
+$9.41M |
| 4 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$8.18M |
| 5 |
Snap
SNAP
|
+$7.19M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$18.3M |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$14.1M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$5.32M |
| 4 |
iShares Russell 1000 Growth ETF
IWF
|
+$4.53M |
| 5 |
Vanguard Morningstar Small-Cap ETF
VB
|
+$4.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 54.33% |
| 2 | Technology | 13.72% |
| 3 | Financials | 8.08% |
| 4 | Healthcare | 7.07% |
| 5 | Consumer Discretionary | 5.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2251
Blue Bird Corp
BLBD
$1.98B
| $2K | ﹤0.01% |
+90
| New | +$1.32K |
2020 Q4
0 quarters
|
|
2252
Strata Critical Medical Inc
SRTA
$405M
| $2K | ﹤0.01% |
+200
| New | +$2.04K |
2020 Q4
0 quarters
|
|
2253
Blackbaud
BLKB
$2.33B
| $2K | ﹤0.01% |
38
-25
| -40% | -$1.39K |
2020 Q1
3 quarters
|
|
2254
BOK Financial
BOKF
$7.6B
| $2K | ﹤0.01% |
31
-4
| -11% | -$258 |
2016 Q4
16 quarters
|
|
2255
DELISTED
Blueprint Medicines
BPMC
| $2K | ﹤0.01% |
21
| – | – |
2019 Q2
6 quarters
|
|
2256
BrightSpire Capital
BRSP
$466M
| $2K | ﹤0.01% |
257
| – | – |
2020 Q2
2 quarters
|
|
2257
Avis
CAR
$3.77B
| $2K | ﹤0.01% |
56
-119
| -68% | -$4.18K |
2020 Q1
3 quarters
|
|
2258
Cass Information Systems
CASS
$695M
| $2K | ﹤0.01% |
39
| – | – |
2016 Q4
16 quarters
|
|
2259
COPT Defense Properties
CDP
$3.77B
| $2K | ﹤0.01% |
84
-135
| -62% | -$3.4K |
2016 Q4
16 quarters
|
|
2260
Cadiz
CDZI
$322M
| $2K | ﹤0.01% |
196
-202
| -51% | -$2.02K |
2020 Q1
3 quarters
|
|
2261
Global X MSCI China Consumer Discretionary ETF
CHIQ
$103M
| $2K | ﹤0.01% |
+49
| New | +$1.57K |
2020 Q4
0 quarters
|
|
2262
Costamare
CMRE
$1.7B
| $2K | ﹤0.01% |
221
-1,044
| -83% | -$7.27K |
2020 Q1
3 quarters
|
|
2263
Coherent
COHR
$46.5B
| $2K | ﹤0.01% |
+20
| New | +$1.19K |
2020 Q4
0 quarters
|
|
2264
DELISTED
Mr. Cooper
COOP
| $2K | ﹤0.01% |
78
| – | – |
2016 Q4
16 quarters
|
|
2265
Coty
COTY
$2.79B
| $2K | ﹤0.01% |
342
| – | – |
2016 Q4
16 quarters
|
|
2266
Central Pacific Financial
CPF
$937M
| $2K | ﹤0.01% |
93
| – | – |
2016 Q4
16 quarters
|
|
2267
CTS Corp
CTS
$1.57B
| $2K | ﹤0.01% |
44
| – | – |
2020 Q1
3 quarters
|
|
2268
Cytosorbents Corp
CTSO
$11.2M
| $2K | ﹤0.01% |
11
| – | – |
2019 Q4
4 quarters
|
|
2269
CubeSmart
CUBE
$8.78B
| $2K | ﹤0.01% |
61
-71
| -54% | -$2.38K |
2016 Q4
16 quarters
|
|
2270
Camping World
CWH
$290M
| $2K | ﹤0.01% |
61
-121
| -66% | -$3.54K |
2020 Q2
2 quarters
|
|
2271
Community Health Systems
CYH
$409M
| $2K | ﹤0.01% |
+266
| New | +$1.88K |
2020 Q4
0 quarters
|
|
2272
Designer Brands
DBI
$314M
| $2K | ﹤0.01% |
217
-695
| -76% | -$4.62K |
2020 Q1
3 quarters
|
|
2273
DRDGold
DRD
$2.17B
| $2K | ﹤0.01% |
160
| – | – |
2020 Q1
3 quarters
|
|
2274
Emergent Biosolutions
EBS
$331M
| $2K | ﹤0.01% |
+21
| New | +$1.93K |
2020 Q4
0 quarters
|
|
2275
Enanta Pharmaceuticals
ENTA
$322M
| $2K | ﹤0.01% |
47
-53
| -53% | -$2.33K |
2020 Q2
2 quarters
|
|
Similar funds
Parallel Advisors's Q4 2020 Portfolio in Review
As of Q4 2020, Parallel Advisors held 2,856 positions worth $1.84B, up 14% from $1.62B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Parallel Advisors's Q4 2020 filing shows 200 new, 717 increased, 1,072 reduced and 193 closed positions. Its largest new stake was Inari Medical, Inc. Common Stock: 59,852 shares worth $5.22M. The largest sale was Microsoft, an estimated $18.3M.
By sector, the portfolio is most concentrated in Miscellaneous at 54% of assets, down from 56% a quarter earlier, followed by Technology and Financials.
- Parallel Advisors's largest Q4 2020 buy was Inari Medical, Inc. Common Stock: 59,852 shares worth $5.22M.
- Parallel Advisors added most to iShares US Treasury Bond ETF in Q4 2020, an estimated $14.5M increase.
- Parallel Advisors's biggest Q4 2020 reduction was Microsoft, cutting an estimated $18.3M.
- Parallel Advisors fully exited Livongo Health, Inc. Common Stock in Q4 2020, selling an estimated $926K.
- Parallel Advisors's ten largest holdings make up 36% of its $1.84B portfolio in Q4 2020.
- Parallel Advisors opened 200 new positions and closed 193 in Q4 2020.
- Parallel Advisors's portfolio value rose 14% quarter-over-quarter to $1.84B.
Based on Parallel Advisors's 13F filing for Q4 2020, filed 2 Feb 2021.